This program will be hybrid. Please attend in-person or virtually!
Kasey Bamel, DNP - University of California San Diego Moores Cancer Center
Christopher Coyne, MD, MPH - University of Califoria San Diego Health
Misako Nagasaka, MD, PhD - UCI Irvine
Sandip P. Patel, MD - University of California San Diego Moores Cancer Center
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading authorities in tumor immunology and cancer immunotherapy, at the conclusion of this activity, participants of this should be able to:
- Summarize recent updates in cancer immunotherapy for lung cancer and toxicity management for key disease states.
- Implement cancer immunotherapy for lung cancer into clinical practice appropriately.
- Describe management approaches for difficult or refractory immune-related adverse events.
- Describe the use of biomarkers to select appropriate cancer immunotherapies for lung cancer patients.
Attendees will also have an opportunity for connecting with experts in the immunotherapy field at the live event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.
For more information on the program, click below.
View the SITC Meeting Code of Conduct.